Medicare Enrolled
Dr. Eduardo Escorcia,, MD
Anesthesiology · Dallas, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Escorcia, from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Escorcia,?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Escorcia,
Dr. Eduardo Escorcia, is an anesthesiology specialist in Dallas, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Escorcia, performed 2,989 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Escorcia, received a total of $4,894 from 43 pharmaceutical and/or device companies across 200 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Escorcia, is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in GA
$4,894 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,989
Medicare services
Top 3% in GA for anesthesiology
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
515 | $94 | $397 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
428 | $66 | $282 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
407 | $61 | $188 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
326 | $47 | $191 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
150 | $47 | $220 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
140 | $194 | $601 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
125 | $105 | $629 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
113 | $149 | $725 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
102 | $111 | $355 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
99 | $153 | $470 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
83 | $97 | $635 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
82 | $56 | $368 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
63 | $41 | $162 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
60 | $78 | $502 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $125 | $523 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
47 | $54 | $306 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
33 | $85 | $339 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
33 | $151 | $580 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
31 | $111 | $814 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
28 | $46 | $189 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
27 | $63 | $439 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
23 | $37 | $145 |
| Injection, methylprednisolone acetate, 40 mg | 20 | $4 | $6 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,894
Total received (2018-2024)
Avg $699/year across 7 years
Top 7% in GA for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
200
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$368
2023
$343
2022
$642
2021
$1,244
2020
$603
2019
$488
2018
$1,207
Payments by company (2024)
BIOTRONIK NRO, Inc.
$86
Stryker Corporation
$59
Medtronic, Inc.
$50
Saluda Medical Americas, Inc.
$47
Boston Scientific Corporation
$41
Curonix LLC
$35
Abbott Laboratories
$23
Collegium Pharmaceutical, Inc.
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$1,402
Abbott Laboratories
$680
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$367
VGI Medical, LLC
$273
Boston Scientific Corporation
$223
Collegium Pharmaceutical, Inc.
$209
Daiichi Sankyo Inc.
$198
BOSTON SCIENTIFIC CORPORATION
$156
Flexion Therapeutics, Inc.
$100
Medtronic USA, Inc.
$94
BIOTRONIK NRO, Inc.
$86
Forte Bio-Pharma LLC
$81
Medtronic, Inc.
$80
Stimwave Technologies Incorporated
$75
PFIZER INC.
$75
Purdue Pharma L.P.
$70
RedHill Biopharma Inc.
$62
Stryker Corporation
$59
Relievant Medsystems, Inc.
$59
Curonix LLC
$51
Saluda Medical Americas, Inc.
$47
BioDelivery Sciences International, Inc.
$43
Kaleo, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$30
Shionogi Inc
$24
ARBOR PHARMACEUTICALS, INC.
$24
Egalet US Inc
$23
Allergan Inc.
$22
Averitas Pharma Inc.
$20
Scilex Pharmaceuticals Inc.
$19
FORTE BIO-PHARMA LLC
$19
Amgen Inc.
$19
Flowonix Medical Incorporated
$18
Hikma Pharmaceuticals USA
$18
SCILEX PHARMACEUTICALS INC.
$17
ASSERTIO THERAPEUTICS, Inc.
$17
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$16
Almatica Pharma LLC
$16
Supernus Pharmaceuticals, Inc.
$15
Pernix Therapeutics Holdings, Inc.
$12
Sentynl Therapeutics, Inc.
$12
AstraZeneca Pharmaceuticals LP
$11
Amniox Medical, Inc.
$10
Top 3 companies account for 50.0% of all-time payments
Associated products mentioned in payments ›
Amitiza · BELBUCA · BOTOX THERAPEUTIC · Cambia · Evoke · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Kloxxado · LYRICA · Levorphanol · MILD DEVICE KIT · MOVANTIK · MYSTIM · Morphabond ER · Movantik · NEOX · Nalocet · Omnia · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · Prospera · QUTENZA · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · SCS IPGs · SPRIX · SUPERION · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · SiJoin/VerteLoc · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Symproic · TROKENDI XR · WAVEWRITER ALPHA · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Anesthesiologists in nearby ZIP areas
91
County median income
$94,557
Nearest hospital to ZIP centroid (approximate)
WELLSTAR PAULDING MEDICAL CENTER
6.1 mi
6.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Escorcia, is a clinical cardiology specialist, with above-average Medicare volume (top 3% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Escorcia, experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Escorcia, performed 515 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Escorcia, receive payments from pharmaceutical companies?
Yes. Dr. Escorcia, received a total of $4,894 from 43 companies across 200 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Escorcia,'s costs compare to other anesthesiologists in Dallas?
Dr. Escorcia,'s average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Escorcia,) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Dallas
Browse anesthesiologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in GA
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in GA
Which GA anesthesiologists receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology